Probiotics in the treatment of acute intestinal infections in children (Review of scientific publications)

Acute intestinal infections (AII) remain one of the pressing health problems. The incidence of AII in children is significantly higher than in adults. Despite the significant diversity of AII pathogens, the composition of the intestinal microbiocenosis plays a significant role in the pathogenesis of the disease. An analysis of publications in the PubMed, EM BASE and Web of Science systems from December 2000 to June 2024 was carried out, covering studies on the clinical use of probiotics for AII in children.

The analysis of the literature data shows that the treatment and prevention of AII are the most reliable indication for the use of probiotics, including in relation to children. At present, there is reliable evidence of the effectiveness of probiotic strains both in the treatment and prevention of intestinal infections. Thus, the results of numerous studies have confirmed that probiotics are a safe means used both for the prevention and treatment of AII. They are one of the key components of the pathogenetic therapy of AII in children. Based on systematic reviews and randomized controlled trials, it has been established that the use of probiotics helps to reduce the duration and severity of AII symptoms. The most significant effects have been demonstrated in relation to the treatment of AII of viral etiology. Evaluation of the effectiveness of probiotics in the prevention of diarrhea episodes varies depending on the etiology of the pathogen, age, concomitant pathology and immune status of patients, which indicates the need for further research in this area. The problems with the dosage and duration of probiotic therapy for various nosological forms of AII in children remain not fully resolved. Multi-strain probiotics require further study.

1. Potapova T., Ermolenko K., Holin A., Stalevskaja A., Gordeeva S., Razd’jakonova I. Zabolevaemost’ ostrymi kishechnymi infekcijami v Sankt-Peterburge na fone pandemii COVID-19 // Zhurnal infektologii. – 2022. – T. 14, № 3. – C. 37-44.

2. Applegate J. A., Fischer Walker C. L., Ambikapathi R., Black R. E. Systematic review of probiotics for the treatment of community-acquired acute diarrhea in children // BMC public health. – 2013. – T. 13. – C. 1-8.

3. Moon R. C., Bleak T. C., Rosenthal N. A., Couturier B., Hemmert R., Timbrook T. T., Brown H., Fang F. C. Epidemiology and Economic Burden of Acute Infectious Gastroenteritis Among Adults Treated in Outpatient Settings in US Health Systems // The American Journal of Gastroenterology. – 2023. – T. 118, № 6. – C. 1069.

4. Sergevnin V. I. Sovremennye tendencii v mnogoletnej dinamike zabolevaemosti ostrymi kishechnymi infekcijami bakterial’noj i virusnoj jetiologii // Jepidemiologija i vakcinoprofilaktika. – 2020. – T. 19, № 4. – C. 14-19.

5. Podkolzin A. T., Kurochkina D. E., Shipulin G. A. Sezonnye i territorial’nye osobennosti raspredelenija zabolevaemosti rotavirusnoj infekciej v RF // Jepidemiologija i infekcionnye bolezni. – 2015. – T. 20, № 2. – C. 52-54.

6. Usenko D., Gorelova E. Ostrye kishechnye infekcii virusnoj jetiologii u detej: vozmozhnosti diagnostiki i terapii // Medicinskij sovet. – 2017. № 9. – C. 86-92.

7. Kesavelu D., Jog P. Current understanding of antibiotic-associated dysbiosis and approaches for its management // Therapeutic advances in infectious disease. – 2023. – T. 10. – C. 20499361231154443.

8. Twitchell E. L., Tin C., Wen K., Zhang H., Becker-Dreps S., Azcarate-Peril M. A., Vilchez S., Li G., Ramesh A., Weiss M. Modeling human enteric dysbiosis and rotavirus immunity in gnotobiotic pigs // Gut pathogens. – 2016. – T. 8, № 1. – C. 1-18.

9. WHO child growth standards: length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: methods and development. / Organization W. H.: World Health Organization, 2006.

10. Barbosa J.C., Machado D., Almeida D., Andrade J.C., Brandelli A., Gomes A.M., Freitas A.C. Next-generation probiotics // ProbioticsElsevier, 2022. – C. 483-502.

11. Saarela M., Mogensen G., Fonden R., Mättö J., Mattila-Sandholm T. Probiotic bacteria: safety, functional and technological properties // Journal of biotechnology. – 2000. – T. 84, № 3. – C. 197-215.

12. Saarela M. H. Safety aspects of next generation probiotics // Current Opinion in Food Science. – 2019. – T. 30. – C. 8-13.

13. Mazziotta C., Tognon M., Martini F., Torreggiani E., Rotondo J. C. Probiotics mechanism of action on immune cells and beneficial effects on human health // Cells. – 2023. – T. 12, № 1. – C. 184.

14. Latif A., Shehzad A., Niazi S., Zahid A., Ashraf W., Iqbal M. W., Rehman A., Riaz T., Aadil R. M., Khan I. M. Probiotics: mechanism of action, health benefits and their application in food industries // Frontiers in Microbiology. – 2023. – T. 14.

15. Szajewska H., Canani R. B., Domell f M., Guarino A., Hojsak I., Indrio F., Vecchio A. L., Mihatsch W. A., Mosca A., Salvatore S. Probiotics for the management of pediatric gastrointestinal disorders: position paper of the ESPGHAN Special Interest Group on Gut Microbiota and Modifications // Journal of pediatric gastroenterology and nutrition. – 2023. – T. 76, № 2. – C. 232-247.

16. Szajewska H., Berni Canani R., Domell f M., Guarino A., Hojsak I., Indrio F., Lo Vecchio A., Mihatsch W. A., Mosca A., Orel R. Probiotics for the management of pediatric gastrointestinal disorders: position paper of the ESPGHAN Special Interest Group on Gut Microbiota and Modifications // Journal of Pediatric Gastroenterology and Nutrition. – 2022. – T. 76, № 2. – C. 232-247.

17. Singh T. P., Natraj B. H. Next-generation probiotics: a promising approach towards designing personalized medicine // Critical Reviews in Microbiology. – 2021. – T. 47, № 4. – C. 479-498.

18. Br ssow H. Probiotics and prebiotics in clinical tests: an update // F1000Research. – 2019. – T. 8.

19. Plaza-Diaz J., Ruiz-Ojeda F. J., Gil-Campos M., Gil A. Mechanisms of action of probiotics // Advances in nutrition. – 2019. – T. 10, № suppl_1. – C. S49-S66.

20. Szajewska H., Guarino A., Hojsak I., Indrio F., Kolacek S., Shamir R., Vandenplas Y., Weizman Z. Use of probiotics for management of acute gastroenteritis: a position paper by the ESPGHAN Working Group for Probiotics and Prebiotics // Journal of pediatric gastroenterology and nutrition. – 2014. – T. 58, № 4. – C. 531-539.

21. Lu Y., Han S., Zhang S., Wang K., Lv L., McClements D. J., Xiao H., Berglund B., Yao M., Li L. The role of probiotic exopolysaccharides in adhesion to mucin in different gastrointestinal conditions // Current Research in Food Science. – 2022. – T. 5. – C. 581-589.

22. Biswas S., Bal B. Comparative, randomized-controlled trial on efficacy and safety of Lactobacillus rhamnosus GG and Saccharomyces boulardii in treatment of acute diarrhea in Indian children (COMPARE-GG trial) // International Journal. – 2023. – T. 10, № 2. – C. 131.

23. Sanklecha M., Verma L., Pai U., Mishra S., Maqsood S., Birla A. Lactobacillus rhamnosus GG evaluation in acute diarrhea (LEAD): An observational study // Cureus. – 2022. – T. 14, № 4.

24. Mahyar A., Ayazi P., Pashaei H., Arad B., Oveisi S., Esmaeili S. The effect of the yeast probiotic Saccharomyces boulardii on acute diarrhea in children // Journal of Comprehensive Pediatrics. – 2021. – T. 12, № 4.

25. Saviano A., Brigida M., Migneco A., Gunawardena G., Zanza C., Candelli M., Franceschi F., Ojetti V. Lactobacillus reuteri DSM 17938 (Limosilactobacillus reuteri) in diarrhea and constipation: Two sides of the same coin? // Medicina. – 2021. – T. 57, № 7. – C. 643.

26. Sun X., Kong J., Zhu S., Liu C. A systematic review and meta-analysis: the therapeutic and preventive effect of Lactobacillus reuteri DSM 17,938 addition in children with diarrhea // BMC gastroenterology. – 2023. – T. 23, № 1. – C. 141.

27. Hojsak I., Kolaček S. Role of Probiotics in the Treatment and Prevention of Common Gastrointestinal Conditions in Children // Pediatric Gastroenterology, Hepatology & Nutrition. – 2024. – T. 27, № 1. – C. 1.

28. Tremblay A., Bronner S., Binda S. Review and Perspectives on Bifidobacterium lactis for Infants’ and Children’s Health // Microorganisms. – 2023. – T. 11, № 10. – C. 2501.

29. Săsăran M.O., Mărginean C.O., Adumitrăchioaiei H., Meliț L. E. Pathogen-specific benefits of probiotic and Synbiotic use in childhood acute gastroenteritis: an updated review of the literature // Nutrients. – 2023. – T. 15, № 3. – C. 643.

30. Cheng H., Ma Y., Liu X., Tian C., Zhong X., Zhao L. A systematic review and meta-analysis: Lactobacillus acidophilus for treating acute gastroenteritis in children // Nutrients. – 2022. – T. 14, № 3. – C. 682.

31. Ouwehand A. C., Invernici M., Messora M. R., Furlaneto F. Multistrain Probiotics and Benefits to Consumer’s Health // Probiotics and Prebiotics in Foods. – 2021. – C. 81.

32. Ryan J. J., Patno N. M. Short-term tolerability, safety, and gut microbial composition responses to a multi-strain probiotic supplement: an open-label study in healthy adults // Integrative Medicine: A Clinician’s Journal. – 2021. – T. 20, № 1. – C. 24.

33. Capurso L. Thirty years of Lactobacillus rhamnosus GG: a review // Journal of clinical gastroenterology. – 2019. – T. 53. – C. S1-S41.

34. Schnadower D., Tarr P. I., Casper T. C., Gorelick M. H., Dean J. M., O’Connell K. J., Mahajan P., Levine A. C., Bhatt S. R., Roskind C. G. Lactobacillus rhamnosus GG versus placebo for acute gastroenteritis in children // New England Journal of Medicine. – 2018. – T. 379, № 21. – C. 2002-2014.

35. Ivashkin V., Maev I., Abdulganieva D., Alekseenko S., Gorelov A., Zaharova I., O Ju Z., Ivashkina N., Korochanskaja N., Mammaev S. Prakticheskie rekomendacii Nauchnogo soobshhestva po sodejstviju klinicheskomu izucheniju mikrobioma cheloveka (NSOIM) i Rossijskoj gastrojenterologicheskoj associacii (RGA) po primeneniju probiotikov, prebiotikov, sinbiotikov i obogashhennyh imi funkcional’nyh pishhevyh produktov dlja lechenija i profilaktiki zabolevanij gastrojenterologicheskogo profilja u detej i vzroslyh // Rossijskij zhurnal gastrojenterologii, gepatologii, koloproktologii. – 2021. – T. 31, № 2. – C. 65-91.

36. Massacci F. R., Lovito C., Tofani S., Tentellini M., Genovese D. A., De Leo A. A. P., Papa P., Magistrali C. F., Manuali E., Trabalza-Marinucci M. Dietary Saccharomyces cerevisiae boulardii CNCM I-1079 positively affects performance and intestinal ecosystem in broilers during a Campylobacter jejuni infection // Microorganisms. – 2019. – T. 7, № 12. – C. 596.

37. Schnadower D., O’Connell K. J., VanBuren J. M., Vance C., Tarr P. I., Schuh S., Hurley K., Rogers A. J., Poonai N., Roskind C. G. Association between diarrhea duration and severity and probiotic efficacy in children with acute gastroenteritis // Official journal of the American College of Gastroenterology| ACG. – 2021. – T. 116, № 7. – C. 1523-1532.

38. Poon T., Juana J., Noori D., Jeansen S., Pierucci-Lagha A., Musa-Veloso K. Effects of a fermented dairy drink containing Lacticaseibacillus paracasei subsp. paracasei CNCM I-1518 (Lactobacillus casei CNCM I-1518) and the standard yogurt cultures on the incidence, duration, and severity of common infectious diseases: a systematic review and meta-analysis of randomized controlled trials // Nutrients. – 2020. – T. 12, № 11. – C. 3443.

39. Rau S., Gregg A., Yaceczko S., Limketkai B. Prebiotics and Probiotics for Gastrointestinal Disorders // Nutrients. – 2024. – T. 16, № 6. – C. 778.

40. Mankevich R., Savich O., Zavada A., Kudin A. Osobennosti terapii rotavirusnoj infekcii u detej na sovremennom jetape // Pediatrija. Vostochnaja Evropa. – 2016. – T. 4, № 2. – C. 277-282.

41. Ploskireva A. A., Gorelov A. V. Taktika probioticheskoj terapii pri ostryh kishechnyh infekcijah u detej // Voprosy prakticheskoj pediatrii. – 2015. – T. 10, № 2. – C. 40-46.

42. Petrova M. I., Reid G., Ter Haar J. A. Lacticaseibacillus rhamnosus GR-1, aka Lactobacillus rhamnosus GR-1: past and future perspectives // Trends in microbiology. – 2021. – T. 29, № 8. – C. 747-761.

43. Vanderhoof J. A., Whitney D. B., Antonson D. L., Hanner T. L., Lupo J. V., Young R. J. Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children // The Journal of pediatrics. – 1999. – T. 135, № 5. – C. 564-568.

44. Ermolenko K. D. Vozmozhnosti prognozirovanija neblagoprijatnyh ishodov kampilobakterioza u detej // Detskie infekcii. – 2023. – T. 22, № 1 (82). – C. 14-18.

45. Jurlova E. V., Grigorovich M. S., Chastoedova I. A. Sostojanie fermentovydelitel’noj funkcii pri ostryh kishechnyh infekcijah u detej na fone probioticheskoj korrekcii // Voprosy prakticheskoj pediatrii. – 2011. – T. 6, № 4. – C. 71-75.

46. Novokshonov A. A., Sokolova N., Berezhkova T., Saharova A. Klinicheskaja jeffektivnost’ probiotika «Acipol» v kompleksnoj terapii OKI bakterial’noj, virusnoj i virusno-bakterial’noj jetiologii u detej // Detskie infekcii. – 2009. – T. 8, № 4. – C. 49-53.

47. McFarland L. V. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease // Official journal of the American College of Gastroenterology| ACG. – 2006. – T. 101, № 4. – C. 812-822.

48. Guo Q., Goldenberg J. Z., Humphrey C., El Dib R., Johnston B. C. Probiotics for the prevention of pediatric antibiotic-associated diarrhea // Cochrane Database of Systematic Reviews. – 2019. № 4.

49. Ashraf R., Shah N. P. Immune system stimulation by probiotic microorganisms // Critical reviews in food science and nutrition. – 2014. – T. 54, № 7. – C. 938-956.

50. Mitra A. K., Asala A. F., Malone S., Mridha M. K. Effects of Probiotics in Adults with Gastroenteritis: A Systematic Review and Meta-Analysis of Clinical Trials // Diseases. – 2023. – T. 11, № 4. – C. 138.

51. Tan-Lim C. S. C., Esteban-Ipac N. A. R., Recto M. S. T., Castor M. A. R., Casis-Hao R. J., Nano A. L. M. Comparative effectiveness of probiotic strains on the prevention of pediatric atopic dermatitis: a systematic review and network meta-analysis // Pediatric Allergy and Immunology. – 2021. – T. 32, № 6. – C. 1255-1270.

52. Pringle K., Lopman B., Vega E., Vinje J., Parashar U. D., Hall A. J. Noroviruses: epidemiology, immunity and prospects for prevention // Future microbiology. – 2015. – T. 10, № 1. – C. 53-67.

53. McFarland L. V. Meta-analysis of probiotics for the prevention of traveler’s diarrhea // Travel medicine and infectious disease. – 2007. – T. 5, № 2. – C. 97-105.

54. Guarino A., Guandalini S., Vecchio A. L. Probiotics for prevention and treatment of diarrhea // Journal of clinical gastroenterology. – 2015. – T. 49. – C. S37-S45.

55. Doron S., Gorbach S. L. Probiotics: their role in the treatment and prevention of disease // Expert review of anti-infective therapy. – 2006. – T. 4, № 2. – C. 261-275.

56. Su G. L., Ko C. W., Bercik P., Falck-Ytter Y., Sultan S., Weizman A. V., Morgan R. L. AGA clinical practice guidelines on the role of probiotics in the management of gastrointestinal disorders // Gastroenterology. – 2020. – T. 159, № 2. – C. 697-705.

57. Cook C. M., Makino H., Kato K., Blonquist T., Derrig L., Shibata H. The probiotic Lacticaseibacillus paracasei strain Shirota (LcS) in a fermented milk beverage survives the gastrointestinal tract of generally healthy US Adults // International Journal of Food Sciences and Nutrition. – 2023. – T. 74, № 5. – C. 645-653.

58. Higuchi T., Furuichi M., Maeda N., Tsugawa T., Ito K. Effects of probiotics in children with acute gastroenteritis: a systematic review and meta-analysis focusing on probiotics utilized in Japan // Journal of Infection and Chemotherapy. – 2024. – T. 30, № 4. – C. 337-342.